| Name | Title | Contact Details |
|---|
Electra-Med Corp is a Flint, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Word and Brown is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
University Medical Center of Southern Nevada is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Las Vegas, NV. To find more information about University Medical Center of Southern Nevada, please visit www.umcsn.com
At Curo, we are committed to clinical excellence and integrity, insuring our patients the highest quality of care and comfort. To maintain this commitment we hire only the most experienced and capable hospice and home health care professionals. Our clinical team members are experts in pain and symptom management, and our support team members are skilled in the specific issues of emotional support, spiritual counseling, and resource referral.